Related Articles
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment
Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma
Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle